NCT01482117

The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers

Randomized, Open-label, Crossover Study to Evaluate the Effect of Genetic Polymorphism on Pharmacokinetic & Pharmacodynamic Interactions of Clopidogrel and Cilostazol in Korean Healthy Adult Volunteers

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: Inje University · Academic / Other
• Sex: Male
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The aim of this study is to investigate the effects of genetic polymorphisms on pharmacokinetic and pharmacodynamic interactions of clopidogrel and cilostazol in Korean healthy adult volunteers.

Conditions

• Interaction

Interventions

Type	Name	Description
DRUG	Clopidogrel	single oral administration of 300mg of clopidogrel
DRUG	Cilostazol	single oral administration of 100mg cilostazol
DRUG	Clopidogrel/Cilostazol	single oral administration of 300mg clopidogrel and 100mg cilostazol

Timeline

• Start date: 2011-11-01
• Primary completion: 2012-01-01
• Completion: 2012-02-01
• First posted: 2011-11-30
• Last updated: 2013-06-03